Publisher Mary Ann Liebert, Inc., publishers, US, has announced that the Advanced Technologies & Treatments for Diabetes (ATTD) Conference has selected Diabetes Technology & Therapeutics (DTT) as its official journal. Edited by Dr. Satish Garg, DTT is published by Mary Ann Liebert, Inc., publishers.
ATTD and DTT both represent the leading conference and journal, respectively, in the field of new technologies and treatments for diabetes. The Journal is available in 170 countries around the world.
DTT and ATTD have been working together for several years on the annual ATTD Yearbook which covers the leading topics and controversies in the field of diabetes and is authored by key international opinion leaders in their area of expertise. The Journal has also released the abstracts for the ATTD 2014 meeting - the 7th International Conference on Advanced Technologies & Treatments for Diabetes - which opened February 5 in Vienna, Austria, and continues through February 8.
Diabetes Technology & Therapeutics is a monthly peer-reviewed journal that covers new technology and new products for the treatment, monitoring, diagnosis, and prevention of diabetes and its complications. Technologies include noninvasive glucose monitoring, implantable continuous glucose sensors, novel routes of insulin administration, genetic engineering, the artificial pancreas, measures of long-term control, computer applications for case management, telemedicine, the Internet, and new medications.
